treatment of MCDS
MCDS-Therapy
repurposing of CBZ
treatment of skeletal dysplasia Genetic skeletal diseases
treatment of epilepsy
treatment strategy
validated mouse model of MCDS
ER stress
group of related genetic skeletal diseases
Mutant collagen X molecules
expression of mutant collagen X
complex group of rare genetic diseases
GSDs
clinical trial
Repurposing of carbamazepine
repurposed therapy
extensive pre-clinical studies
world-renown clinical centres
biomarker development
orphan drug designation
FDA approved drug
health economics assessment studies
bone growth
poor quality of life
AUS
bipolar disorder
SMEs
European Commission
results
year collaborative project
type Schmid
hypertrophic chondrocytes
severity
disability
fold
mutations
generic form
high healthcare costs
member states
Marketing Authorization Application dossier
prognosis tools
well-characterised phenotypes
pain
candidate countries
endoplasmic reticulum
Phase1
synthesis
Metaphyseal chondrodysplasia
overall prevalence
diagnosis
lethal forms
people
Phase2
minimum
children
burden
skeleton
population